Speech Language Pathologist (SLP) in Dallas, TX

Make a meaningful difference in students’ lives by providing vital speech and language support across K-12 classrooms in a welcoming and supportive educational setting near Dallas, TX. This full-time, contract opportunity is perfect for professionals ready to contribute their expertise in helping students reach their communication goals.

Start your school year on August 13, 2026, and continue through May 21, 2027, working a consistent 40-hour workweek with guaranteed hours. As a Speech Language Pathologist, you’ll play an essential role in fostering progress through both direct and indirect services, without being tasked with additional non-therapy school duties.

Qualifications:

• Master’s Degree in Speech-Language Pathology
• Current or eligible Texas SLP license
• Certification of Clinical Competence (CCC-SLP) or Clinical Fellowship Year (CFY) candidates encouraged to apply
• Experience or interest in working K-12 caseloads within school-based settings
• Strong communication, organization, and documentation skills

Responsibilities:

• Deliver assessment, treatment, and intervention services to diverse K-12 students
• Develop and implement Individualized Education Plans (IEPs)
• Collaborate with educators, families, and support staff to optimize student progress
• Maintain accurate records and compliance with state and district requirements
• Participate in meetings as related to therapy, with guaranteed time dedicated to both direct and indirect services

Perks Include:

• Guaranteed weekly hours
• Focus solely on therapy—no mandatory assignments like bus or lunch duty
• Stipends available for qualifying travel therapists

Eligible full-time employees can also access comprehensive benefits, including healthcare, vision, dental coverage, and a 401(k) plan.

Step into a rewarding school-based SLP position where your expertise is valued, your time is protected, and your growth supported. Apply now to begin your journey making a positive impact in students’ futures.